240 related articles for article (PubMed ID: 33976742)
1. The Yunnan national medicine Maytenus compound inhibits the proliferation of hepatocellular carcinoma (HCC) by suppressing the activation of the EGFR-PI3K-AKT signaling pathway.
Zhao WT; Han LX; Liu L; Zeng BZ; Zhang Y; Zhao LF; Hu HY; Xia JW; Li YZ; Xiang XD; Lin XL; Lu D; Li GF
J Cancer; 2021; 12(11):3325-3334. PubMed ID: 33976742
[No Abstract] [Full Text] [Related]
2. [Effects of cetuximab combined erlotinib on proliferation of human hepatocellular carcinoma cell lines HepG2 and Bel-7402].
Wei W; Guo RP; Li JQ; Xu L; Shi M; Zhang YQ
Ai Zheng; 2008 Apr; 27(4):386-92. PubMed ID: 18423125
[TBL] [Abstract][Full Text] [Related]
3. Anticancer effect of the traditional Chinese medicine herb Maytenus compound via the EGFR/PI3K/AKT/GSK3β pathway.
Zeng B; Ge C; Zhao W; Fu K; Liu L; Lin Z; Fu Q; Li Z; Li R; Guo H; Li C; Zhao L; Hu H; Yang H; Huang W; Huang Y; Song X
Transl Cancer Res; 2019 Sep; 8(5):2130-2140. PubMed ID: 35116963
[TBL] [Abstract][Full Text] [Related]
4. Secalonic Acid-F, a Novel Mycotoxin, Represses the Progression of Hepatocellular Carcinoma via MARCH1 Regulation of the PI3K/AKT/β-catenin Signaling Pathway.
Xie L; Li M; Liu D; Wang X; Wang P; Dai H; Yang W; Liu W; Hu X; Zhao M
Molecules; 2019 Jan; 24(3):. PubMed ID: 30678274
[TBL] [Abstract][Full Text] [Related]
5. Alpinia oxyphylla oil induces apoptosis of hepatocellular carcinoma cells via PI3K/Akt pathway in vitro and in vivo.
Hui F; Qin X; Zhang Q; Li R; Liu M; Ren T; Zhao M; Zhao Q
Biomed Pharmacother; 2019 Jan; 109():2365-2374. PubMed ID: 30551496
[TBL] [Abstract][Full Text] [Related]
6. Eukaryotic elongation factor-1α 2 knockdown inhibits hepatocarcinogenesis by suppressing PI3K/Akt/NF-κB signaling.
Qiu FN; Huang Y; Chen DY; Li F; Wu YA; Wu WB; Huang XL
World J Gastroenterol; 2016 Apr; 22(16):4226-37. PubMed ID: 27122673
[TBL] [Abstract][Full Text] [Related]
7. Crebanine induces ROS-dependent apoptosis in human hepatocellular carcinoma cells
Tan J; Xiang Y; Xiong Y; Zhang Y; Qiao B; Zhang H
Front Pharmacol; 2023; 14():1069093. PubMed ID: 36874025
[No Abstract] [Full Text] [Related]
8. Local anesthetic bupivacaine inhibits proliferation and metastasis of hepatocellular carcinoma cells via suppressing PI3K/Akt and MAPK signaling.
Wang L; Guo W; Guan H; Yan N; Cai X; Zhu L
J Biochem Mol Toxicol; 2021 Oct; 35(10):e22871. PubMed ID: 34338398
[TBL] [Abstract][Full Text] [Related]
9. Lappaconitine Sulfate Inhibits Proliferation and Induces Apoptosis in Human Hepatocellular Carcinoma HepG2 Cells through the Reactive Oxygen Species-Dependent Mitochondrial Pathway.
Zhang X; Ma J; Song N; Guo Y; Hui L; Sang C
Pharmacology; 2020; 105(11-12):705-714. PubMed ID: 32062649
[TBL] [Abstract][Full Text] [Related]
10. Baicalein, a Natural Anti-Cancer Compound, Alters MicroRNA Expression Profiles in Bel-7402 Human Hepatocellular Carcinoma Cells.
Bie B; Sun J; Li J; Guo Y; Jiang W; Huang C; Yang J; Li Z
Cell Physiol Biochem; 2017; 41(4):1519-1531. PubMed ID: 28351032
[TBL] [Abstract][Full Text] [Related]
11. LINC01133 aggravates the progression of hepatocellular carcinoma by activating the PI3K/AKT pathway.
Zheng YF; Zhang XY; Bu YZ
J Cell Biochem; 2019 Mar; 120(3):4172-4179. PubMed ID: 30548306
[TBL] [Abstract][Full Text] [Related]
12. Homoharringtonine inhibits the progression of hepatocellular carcinoma by suppressing the PI3K/AKT/GSK3β/Slug signaling pathway.
Liu HY; Dong TX; Li ZZ; Li TT; Jiang J; Zhu MW; An TT; Chen YD; Yang XH
Neoplasma; 2021 Sep; 68(5):924-937. PubMed ID: 33998239
[TBL] [Abstract][Full Text] [Related]
13. BEZ235 increases sorafenib inhibition of hepatocellular carcinoma cells by suppressing the PI3K/AKT/mTOR pathway.
Li A; Zhang R; Zhang Y; Liu X; Wang R; Liu J; Liu X; Xie Y; Cao W; Xu R; Ma Y; Cai W; Wu B; Cai S; Tang X
Am J Transl Res; 2019; 11(9):5573-5585. PubMed ID: 31632530
[TBL] [Abstract][Full Text] [Related]
14. PES1 enhances proliferation and tumorigenesis in hepatocellular carcinoma via the PI3K/AKT pathway.
Wang J; Sun J; Zhang N; Yang R; Li H; Zhang Y; Chen K; Kong D
Life Sci; 2019 Feb; 219():182-189. PubMed ID: 30630006
[TBL] [Abstract][Full Text] [Related]
15. Estrogen receptor-α36 is involved in diallyl sulfide-induced inhibition of malignant growth of HepG2 and Huh7 hepatocellular carcinoma cells.
Wu W; Chen H; Wang R; Chen J; Yu H; Wei Z; Liu X; Xue M; Chen Q; Zhou H; Fu Z
Environ Toxicol; 2022 Feb; 37(2):270-281. PubMed ID: 34724321
[TBL] [Abstract][Full Text] [Related]
16. Alnustone inhibits the growth of hepatocellular carcinoma via ROS- mediated PI3K/Akt/mTOR/p70S6K axis.
Wang L; Cheng L; Ma L; Ahmad Farooqi A; Qiao G; Zhang Y; Ye H; Liu M; Huang J; Yang X; Lin X; Cao S
Phytother Res; 2022 Jan; 36(1):525-542. PubMed ID: 34847624
[TBL] [Abstract][Full Text] [Related]
17. Celastrus orbiculatus Extracts Inhibit Human Hepatocellular Carcinoma Growth by Targeting mTOR Signaling Pathways.
Qian YY; Li WY; Yan Y; Zhao XY; Yang T; Fang CC; Hou JJ; Liu YQ
Chin J Integr Med; 2019 Nov; 25(11):845-852. PubMed ID: 31127506
[TBL] [Abstract][Full Text] [Related]
18. MST4 inhibits human hepatocellular carcinoma cell proliferation and induces cell cycle arrest via suppression of PI3K/AKT pathway.
Hao WC; Zhong QL; Pang WQ; Dian MJ; Li J; Han LX; Zhao WT; Zhang XL; Xiao SJ; Xiao D; Lin XL; Jia JS
J Cancer; 2020; 11(17):5106-5117. PubMed ID: 32742458
[No Abstract] [Full Text] [Related]
19. Aerobic exercise suppresses hepatocellular carcinoma by downregulating dynamin-related protein 1 through PI3K/AKT pathway.
Zhao T; Guo BJ; Xiao CL; Chen JJ; Lü C; Fang FF; Li B
J Integr Med; 2021 Sep; 19(5):418-427. PubMed ID: 34454893
[TBL] [Abstract][Full Text] [Related]
20. Xihuang pills induce apoptosis in hepatocellular carcinoma by suppressing phosphoinositide 3-kinase/protein kinase-B/mechanistic target of rapamycin pathway.
Teng YJ; Deng Z; Ouyang ZG; Zhou Q; Mei S; Fan XX; Wu YR; Long HP; Fang LY; Yin DL; Zhang BY; Guo YM; Zhu WH; Huang Z; Zheng P; Ning DM; Tian XF
World J Gastrointest Oncol; 2022 Apr; 14(4):872-886. PubMed ID: 35582102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
